CA2342223A1 - Nouvelle composition - Google Patents

Nouvelle composition Download PDF

Info

Publication number
CA2342223A1
CA2342223A1 CA002342223A CA2342223A CA2342223A1 CA 2342223 A1 CA2342223 A1 CA 2342223A1 CA 002342223 A CA002342223 A CA 002342223A CA 2342223 A CA2342223 A CA 2342223A CA 2342223 A1 CA2342223 A1 CA 2342223A1
Authority
CA
Canada
Prior art keywords
treatment
component
pharmaceutical formulation
composition
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002342223A
Other languages
English (en)
Inventor
Seth-Olov Thorberg
John Evenden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2342223A1 publication Critical patent/CA2342223A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une composition constituée d'un premier constituant (a), un monohydrate de (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2-H-1-benzopyrane-5-carboxamide hydrogène (2R,3R)-tartrate, et d'un deuxième constituant (b), un inhibiteur de réinterception de 5-HT, à l'exclusion du citalopram et de la paroxétine; la préparation de celle-ci; des formulations pharmaceutiques contenant ladite composition; une méthode de traitement de troubles affectifs tels que des troubles de l'humeur et des troubles anxieux à l'aide de ladite composition, et l'utilisation de ladite méthode de traitement; et une trousse contenant ladite composition.
CA002342223A 1998-09-16 1999-09-13 Nouvelle composition Abandoned CA2342223A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9803155A SE9803155D0 (sv) 1998-09-16 1998-09-16 A new composition
SE9803155-2 1998-09-16
PCT/SE1999/001596 WO2000015217A1 (fr) 1998-09-16 1999-09-13 Nouvelle composition

Publications (1)

Publication Number Publication Date
CA2342223A1 true CA2342223A1 (fr) 2000-03-23

Family

ID=20412626

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002342223A Abandoned CA2342223A1 (fr) 1998-09-16 1999-09-13 Nouvelle composition

Country Status (6)

Country Link
EP (1) EP1113792A1 (fr)
JP (1) JP2002524507A (fr)
AU (1) AU6377999A (fr)
CA (1) CA2342223A1 (fr)
SE (1) SE9803155D0 (fr)
WO (1) WO2000015217A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2269467T3 (es) 2000-10-13 2007-04-01 Neurosearch A/S Tratamiento de transtornos afectivos por la accion combinada de un agonista del receptor nicotinico y una sustancia monoaminergenica.
WO2010042499A1 (fr) 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Solutions stables d'orlistat pour formes galéniques pharmaceutiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
AU6377999A (en) 2000-04-03
JP2002524507A (ja) 2002-08-06
SE9803155D0 (sv) 1998-09-16
EP1113792A1 (fr) 2001-07-11
WO2000015217A1 (fr) 2000-03-23

Similar Documents

Publication Publication Date Title
US6172105B1 (en) Composition and methods employing it for the treatment of 5-HT-mediated disorders
JP2009538331A (ja) 抑うつ障害のための治療
JP5491475B2 (ja) ムスカリン性受容体ｍ１拮抗剤を使用する精神状態の処置
CA3123248A1 (fr) Methodes pour le traitement de la depression
EP3400940B1 (fr) Acomposés ayant une affinité pour le récepteur de la mélatonine en tant qu'agent prophylactique ou thérapeutique du délire
US6472423B1 (en) Pharmaceutical composition
CA2342585A1 (fr) Nouvelle composition
MXPA04012693A (es) Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina.
CA2342223A1 (fr) Nouvelle composition
CA2342233A1 (fr) Nouvelle composition
CA2342341A1 (fr) Nouvelle composition
KR20060066729A (ko) 우울증 치료를 위한 세로토닌 재흡수 억제제 및 글리신트랜스포터 타입 1 억제제의 조합
MXPA01002543A (en) A new composition
KR20060124639A (ko) 세로토닌 재흡수 억제제 및 히스타민 ３ 수용체안타고니스트, 역 아고니스트 또는 부분 아고니스트의 조합
MXPA01002370A (en) A new composition
KR20010086459A (ko) 코골이 및 해부학적 상부 기도의 높은 저항 증후군 치료용의약의 제조에서 ５ｈｔ２ａ 및 ５ｈｔ２ａ/ｃ 수용체길항제의 용도

Legal Events

Date Code Title Description
FZDE Dead